123 related articles for article (PubMed ID: 22767220)
21. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
22. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
Kim EJ; Hong JE; Eom SJ; Lee JY; Park JH
Breast Cancer Res Treat; 2011 Nov; 130(1):61-71. PubMed ID: 21170677
[TBL] [Abstract][Full Text] [Related]
23. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
[TBL] [Abstract][Full Text] [Related]
24. In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas.
Shibata MA; Ito Y; Morimoto J; Kusakabe K; Yoshinaka R; Otsuki Y
J Gene Med; 2006 Mar; 8(3):335-52. PubMed ID: 16345101
[TBL] [Abstract][Full Text] [Related]
25. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
Lawson KA; Anderson K; Snyder RM; Simmons-Menchaca M; Atkinson J; Sun LZ; Bandyopadhyay A; Knight V; Gilbert BE; Sanders BG; Kline K
Cancer Chemother Pharmacol; 2004 Nov; 54(5):421-31. PubMed ID: 15197487
[TBL] [Abstract][Full Text] [Related]
26. The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.
Wang N; Thuraisingam T; Fallavollita L; Ding A; Radzioch D; Brodt P
Cancer Res; 2006 Mar; 66(6):3062-70. PubMed ID: 16540655
[TBL] [Abstract][Full Text] [Related]
27. Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis.
Jan Treda C; Fukuhara T; Suzuki T; Nakamura A; Zaini J; Kikuchi T; Ebina M; Nukiwa T
Carcinogenesis; 2014 Apr; 35(4):896-904. PubMed ID: 24282288
[TBL] [Abstract][Full Text] [Related]
28. The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells.
Simpkins FA; Devoogdt NM; Rasool N; Tchabo NE; Alejandro EU; Kamrava MM; Kohn EC
Carcinogenesis; 2008 Mar; 29(3):466-72. PubMed ID: 17916899
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo.
Sarti M; Sevignani C; Calin GA; Aqeilan R; Shimizu M; Pentimalli F; Picchio MC; Godwin A; Rosenberg A; Drusco A; Negrini M; Croce CM
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):806-13. PubMed ID: 15701871
[TBL] [Abstract][Full Text] [Related]
30. Secretory leukocyte protease inhibitor: a secreted pattern recognition receptor for mycobacteria.
Gomez SA; Argüelles CL; Guerrieri D; Tateosian NL; Amiano NO; Slimovich R; Maffia PC; Abbate E; Musella RM; Garcia VE; Chuluyan HE
Am J Respir Crit Care Med; 2009 Feb; 179(3):247-53. PubMed ID: 19011154
[TBL] [Abstract][Full Text] [Related]
31. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM
Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
33. Human uterus myoma and gene expression profiling: A novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion.
Mikami Y; Fukushima A; Komiyama Y; Iwase T; Tsuda H; Higuchi Y; Hayakawa S; Kuyama K; Komiyama K
Cancer Lett; 2016 Aug; 379(1):84-93. PubMed ID: 27238568
[TBL] [Abstract][Full Text] [Related]
34. Gastrin suppresses growth of CCK2 receptor expressing colon cancer cells by inducing apoptosis in vitro and in vivo.
Müerköster S; Isberner A; Arlt A; Witt M; Reimann B; Blaszczuk E; Werbing V; Fölsch UR; Schmitz F; Schäfer H
Gastroenterology; 2005 Sep; 129(3):952-68. PubMed ID: 16143134
[TBL] [Abstract][Full Text] [Related]
35. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
[TBL] [Abstract][Full Text] [Related]
36. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response.
Odaka C; Mizuochi T; Yang J; Ding A
J Immunol; 2003 Aug; 171(3):1507-14. PubMed ID: 12874244
[TBL] [Abstract][Full Text] [Related]
37. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
[TBL] [Abstract][Full Text] [Related]
38. Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer.
Liu G; Yang J; Zhao Y; Wang Z; Xing B; Wang L; Shi D
World J Surg Oncol; 2014 Dec; 12():369. PubMed ID: 25441765
[TBL] [Abstract][Full Text] [Related]
39. Secretory leukoprotease inhibitor inhibits cell growth through apoptotic pathway on ovarian cancer.
Nakamura K; Takamoto N; Hongo A; Kodama J; Abrzua F; Nasu Y; Kumon H; Hiramatsu Y
Oncol Rep; 2008 May; 19(5):1085-91. PubMed ID: 18425362
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo.
Devoogdt N; Rasool N; Hoskins E; Simpkins F; Tchabo N; Kohn EC
Cancer Sci; 2009 Mar; 100(3):434-40. PubMed ID: 19154415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
